NASDAQ: CRVL · Insurance Brokers
CorVel (CRVL) fair value: undervalued or overvalued?
As of 26 Sep 2026, Faircurve's model values CorVel (CRVL) at $74.65 a share. The stock last closed at $75.47, which puts the model's fair value 1.1% below the price. On the model's bands that reads as Fairly valued.
Revalued . Price is the close of 2 Oct 2026. CorVel Corporation.
Faircurve Insights · 26 Sep 2026
CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. It is a Financial Services company, in Insurance Brokers.
Faircurve's model on 26 Sep 2026 found a fair value of $74.65 a share, the midpoint of 2,000 simulations. The previous run on 19 Sep 2026 gave $71.31, so the fair value moved +4.7%. The model's calibrated range over 63 trading days, $62.63 to $91.02, held the price 60% of the time at this horizon, and the evidence grade is Medium.
The company's overall quality score is 79 out of 100 against comparable companies. Its profitability score is 100 with ROIC 63.6% (peer median 15.2%), and its balance sheet score is 100 with net debt / EBITDA -1.24x (peer median 2.57x). The model compares CorVel Corporation with Ryan Specialty Holdings, Inc., Brown & Brown, Inc., Willis Towers Watson Public Limited Company, Arthur J. Gallagher & Co., and Marsh & McLennan Companies, Inc. The stock's median move around its last 8 earnings reports, ignoring direction, was 8.2%.
Written from the figures on this page for the 26 Sep 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
What price range does the model give CRVL?
The calibrated range for CRVL over 63 trading days is $62.63 to $91.02. There is no live options data for this stock, so the range is built from the fair value and calibrated weekly against realised prices (n = 4,327 past valuations, refreshed 26 Sep 2026). Ranges built this way held the price 60% of the time at this horizon.
The model's own simulated range, from the 20th to the 80th percentile of its runs, is $51.56 to $104.92. In 50% of the simulations the fair value came out above the price the model ran on.
How does CRVL score on business quality?
CorVel's overall quality score is 79 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.
| Factor | Score (0 to 100) | Headline measure | Peer median |
|---|---|---|---|
| ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend. | 100 | 63.6%ROIC | 15.2% |
| Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash). | 70 | 0.99xFCF / net income | 1.26x |
| Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analyst estimate revisions. | 50 | 7.0%Revenue growth, trailing | 8.3% |
| Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks. | 52 | 1.8%Net buybacks / market value | 4.1% |
| Balance sheetNet debt to EBITDA and interest coverage. | 100 | -1.24xNet debt / EBITDA | 2.57x |
| StabilityDownside volatility of the EBITDA margin over the last five years. | 99 | 0.8 ptsEBITDA margin downside volatility, 5y | 4.1 pts |
How does CRVL compare with similar companies?
The companies in insurance brokers closest to CorVel in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| RYAN Ryan Specialty Holdings, Inc. | $37.67 | $48.34 | +28.3% | Undervalued |
| GSHD Goosehead Insurance, Inc | $45.51 | $45.29 | -0.5% | Low evidence grade |
| BRO Brown & Brown, Inc. | $59.91 | $64.92 | +8.4% | Fairly valued |
| WTW Willis Towers Watson Public Limited Company | $288.61 | $298.29 | +3.4% | Fairly valued |
| AON Aon plc | $269.45 | $288.28 | +7.0% | Low evidence grade |
| AJG Arthur J. Gallagher & Co. | $226.11 | $236.01 | +4.4% | Fairly valued |
| MRSH Marsh & McLennan Companies, Inc. | $170.06 | $171.27 | +0.7% | Fairly valued |
When does CRVL report earnings, and how has the stock reacted?
CorVel's next earnings report is scheduled for 3 Nov 2026. Companies can move their dates.
Options prices on 2 Oct 2026 imply a move of about 9.5% in either direction through the nearest expiry, about 48 days out, a window that includes the report. That is the size the market is pricing, not a direction.
How CRVL moved around its last 8 earnings reports
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across these 8 reports, ignoring direction, was 8.2%.
| Report date | Two session move |
|---|---|
| 5 Aug 2026 | +5.7% |
| 20 May 2026 | +4.6% |
| 3 Feb 2026 | -29.6% |
| 4 Nov 2025 | +3.2% |
| 5 Aug 2025 | +2.1% |
| 22 May 2025 | -10.6% |
| 4 Feb 2025 | +10.8% |
| 5 Nov 2024 | +16.8% |
CorVel at a glance
CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims.
- Market value
- $3.8B
- Sector
- Financial Services
- Industry
- Insurance Brokers
- Beta to the US market
- -0.01
- First valued by Faircurve
- 11 Jul 2026
How the fair value is worked out: the model prices CorVel on the value of the whole business against its operating profit, compared with where that ratio has sat before (EV/EBITDA against its own history), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.
What changed in the latest valuation?
On 19 Sep 2026 the model's fair value for CRVL was $71.31. As of 26 Sep 2026 it is $74.65, a change of +4.7%. The model revalues every stock it covers each week, and again after an earnings report.
Questions about CorVel's valuation
Is CorVel stock undervalued or overvalued?
On Faircurve's model, CRVL reads as Fairly valued as of 26 Sep 2026. The model's fair value is $74.65 a share against a last close of $75.47, a gap of -1.1%.
What is CRVL's fair value?
$74.65 a share as of 26 Sep 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $51.56 to $104.92.
What price range does the model give CRVL?
$62.63 to $91.02 over 63 trading days. Ranges built this way held the price 60% of the time across 4,327 past valuations, refreshed 26 Sep 2026.
When does CorVel report earnings next?
The next report is scheduled for 3 Nov 2026. Companies can move their dates.
How much has CRVL moved on past earnings reports?
Across its last 8 reports the median two session move was 8.2%, ignoring direction. The largest was -29.6% around the report of 3 Feb 2026.
How confident is the model in this valuation?
The model's evidence grade for CRVL is medium. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.